TGFB1 and neoplasm: The binding of TGF-β and SDF-1 to the membrane receptors on the tumor triggers the expression of endothelial markers like VE-cadherin, matrix metalloproteinase (MMP2) and laminin subunit gamma-2 (LAMC2) that could degrade the ECM to form VM (44).